Total synthesis of antitumor acylfulvenes

Details Total synthesis of antitumor acylfulvenes Total synthesis of antitumor acylfulvenes

1997-10-31

1999-01-05

Trinh, Ba K.

Organic compounds -- part of the class 532-570 series

Organic compounds

Oxygen containing

568374, C07C 4557

Patent

active

058565809

ABSTRACT:
The present invention provides a method of synthesizing compounds of formula (I): ##STR1## wherein R and R' are independently (C.sub.1 -C.sub.4)alkyl.

REFERENCES:
patent: 5387578 (1995-02-01), Angelucci et al.
patent: 5439936 (1995-08-01), Kelner et al.
patent: 5439942 (1995-08-01), Kelner et al.
patent: 5523490 (1996-06-01), Kelner et al.
patent: 5563176 (1996-10-01), Kelner et al.
Eva, K.M., et al., "An Efficient Sythesis of Pterosin C and Other Pterosines", Can J. Chem., 62, 1945-1953, (1984).
McMorris, T.C., et al., "An Acetal Derivative of Illudin S with Improved Antitumor Activity", Tetrahedron letters, vol. 38, No. 10, pp. 1697-1698, (1997).
McMorris, T.C., et al., "Design and Synthesis of Antitumor Acylfulvenes", J. Org. Chem, vol. 62,, pp. 3015-3018, (1997).
McMorris, T.C., et al., "Total Synthesis of hydroxymethylacylfulvene, an antitumor derivative of illudin S", Chem. Commun., pp. 315-316, (1997).
Padwa, A., et al., "An approach toward the illudin family of sesquiterpenes using the tandem cyclization-cycloaddition reaction of rhodium carbenoids", J. Org. Chem, vol. 62, pp. 1317-1325, (1997).
Padwa, A., et al., "Generation and Cycloaddition behavior of spirocyclic carbonyl ylides. Application to the synthesis of the Pterosin Family of Sequiterpenes", J. Org. Chem., vol. 61, pp. 73-81, (1996).
Padwa, A., et al., "Synthetic studies toward Illudins and Ptaguilosin. A. Highly Convergent approach via the dipolar cycloaddition of carbonyl ylides", J. Am. Chem. Soc., Vo. 116, pp. 2667-2668, (1994).
Shinozawa, S., et al., "The Antitumor Effect of Illudin S (Lampterol) Entrapped in Liposome for Mice Inolculated with Ehrlich Ascites Tumor Cells", Abstract No. 197682, STN File Server CAS Chemical Abstracts, 90, 1979.
Anchel, M., et al., "Antibiotic Substances from Basidiomycetes. VII. Clitocybe Illudens", Proc. Natl. Acad. Sci. USA, 36 (5), 300-305, (1950).
Anchel, M., et al., "The Biogenesis of Illudins S and M in Clitocybe Illudens", Phytochemistry, 9, 2339-2343, (1970).
Brandsteterova, E., et al., "HPLC Analysis of Novel Anti-Cancer Agents-Illudins and Their Analogs", J. Liquid Chromatography, 16 (1), 115-125, (1993).
Brandsteterova, E., et al., "HPLC Determination of a New Anticancer Agent (Acylfulvene) in Serum", Neoplasma, 39 (6), 369-373, (1992).
Burres, N.S., et al., "Antitumor Activity and Mechanism of Action of the Novel Marine Natural Products Mycalamide-A and -B and Onnamide", Cancer Research, 49, 2935-2940, (Jun. 1989).
Dillman, R.O., et al., "Athymic Mouse Model of a Human T-Cell Tumor", Cancer Research, 45, 5632-5636, (Nov. 1985).
French, A.L., et al., "Poisoning with the North American Jack O' Lantern Mushroom", Clinical Toxicology, 26 (1&2), 81-88, (1988).
Giovanella, B.C., et al., "Correlation Between Response to Chemotherapy of Human Tumors in Patients and in Nude Mice", Cancer, 52, 1146-1152, (1983).
Giovanella, B.C., et al., "DNA Topoisomerase I-Targeted Chemotherapy of Human Colon Cancer in Xenografts", Science, 246, 1046-1048, (Nov. 1989).
Goldin, A., et al., "Current Results of the Screening Program at the Division of Cancer treatment, National Cancer Institute", Europ. J. Cancer,17, 129-142, (1981).
Goldin, A., et al., "Historical Development and Current Strategy of the National Cancer Institute Drug Development Program", In: Methods in Cancer Research, vol. XVI, Academic Press, Inc. 165-245, (1979).
Hanson, J.R., et al., "Studies in Terpenoid Biosynthesis. Part XV. Biosynthesis of the Sesquiterpenoid Illudin M", J.C.S. Perkins I, 876-880, (1976).
Hara, M., et al., "6-Deoxyilludin M, a New Antitumor Antibiotic: Fermentation, Isolation and Structural Identification", The Journal of Antibiotics, 40, 1643-1646, (Nov., 1987).
Harttig, U., et al., "Leaianafulvene, a Sesquiterpenoid Fulvene Derivative from Cultures of Mycena Leaiana", Phytochemistry, 29 (12), 3942-3944, (1990).
Hirono, I., et al., "Repreoduction of Acute Bracken Poisoning in a Calf with Ptaquiloside, a Bracken Constituent", The Veterinary Record, 115, Abstract No. 85067284, STN File Server, File Medline, 375-0378, (Oct., 1984).
Inoue, K., et al., "Antitumor Efficacy of Seventeen Anticancer Drugs in Human Breast Cancer Xenograft (MX-1) Transplanted in Nude Mice", Cancer Chemother. Pharamacol., 10, 182-186, (1983).
Kawato, Y., et al., "Antitumor Activity of a Camptothecin Derivative, CPT-11, Against Human Tumor Xenografts in Nude Mice", Cancer Chemother. Pharmacol., 28, 192-198, (1991).
Kelner, M.J., et al., "In Vitro and In Vivo Studies on the Anticancer Activity of Dehydroilludin M", Anticancer Research, 15, 873-878, (1995).
Kelner, M.J., et al., "Nonresponsiveness of the Metastatic Human Lung Carcinoma MV522 Xenograft to Conventional Anticancer Agents", Anticancer Research, 15, 867-872 (1995).
Kelner, M.J., et al., "Preclinical Evaluation of Illudins as Anticancer Agents", Cancer Research, 47, 3186-3189, (1987).
Kelner, M.J., et al., "Preclinical Evaluation of Illudens as Anticancer Agents: Basis for Selective Cytotoxicity", J. Natl. Cancer Inst., 82 (19), 1562-1565, (1987).
Matsumoto, T., et al., "An Alternative of illudin M", Tetrahedron Letters, 14, 1171-1174, (1970).
Matsumoto, T., et al., "Synthesis of Illudin S", Tetrahedron Letters,23, 2049-2052, (1971).
McMorris, T.C., et al., "(Hydroxymethyl) Acyfulvene: An Illudin Derivative with Superior Antitumor Properties", J. Nat. Prod., 59, 896-899, (1996).
McMorris, T.C., et al., "Acylfulvenes, a New Class of Potent Antitumor Agents", Experientia, 52, 75-80 (1996).
McMorris, T.C., et al., "Fungal Metabolites. The Structures of the Novel Sesquiterpenoids Illudin -S and -M", J. of Amer. Chem. Soc., 87 (7), 1594-1600, (1965).
McMorris, T.C., et al., "On the Mechanism of Toxicity of Illudins: The Role of Glutathione", Chem. Res. Toxicol., 3, 574-579, (1990).
McMorris, T.C., et al., "Structure-Activity Relationships of Illudens: Analogs with Improved Therapeutic Index", J. Org. Chem., 57, 6876-6883, (1992).
McMorris, T.C., et al., "Structure and Reactivity of Illudins", Tetrahedron, 45 (17), 5433-5440, (1989).
Schabel, F.M., et al., "Testing Therapeutic Hypotheses in Mice and Man:Observations on the Therapeutic Activity Against Advanced Solid Tumors of Mice Treated with Anticancer Drugs that Have Demonstrated or Potential Clinical Utility for Treatment of Advanced Solid Tumors of Man", In: Methods in Cancer Research, vol. XVII, Academic Press, Inc., pp. 3-50, (1979).
Shimomura, O., "The Role of Superoxide Dismutase in Regulating the Light Emission of Luminescent Fungi", J. of Experimental Botany, 43, 1519-1525, (1992).
Steel, G.G., et al., "The Response to Chemotherapy of a Variety of Human Tumor Xenografts", Br. J. Cancer, 47, 001-013, (1983).
Tanaka, K., et al., "Metabolism by Rat Liver Cytosol of Illudin S, a Toxic Substance of Lampteromyces Japonicus. II. Characterization of Illudin S-Metabolizing Enzyme", Xenobiotica, 22 (1),, 33-39, (1992).
Tanaka, K., et al., "Metabolism of Illudin S, a Toxic Principle of Lampteromyces Japonicus, by Rat Liver. I. Isolation and Identification of Cyclopropane Ring-Cleavage Metabolites", Xenobiotica, 20 (7), 671-881, (1990).
Varki, N.M., et al., "Cloned Low Metastic Variants from Human Lung Carcinoma Metastases", Anticancer Research, 10, 637-644, (1990).
Vendetti, J.M., et al., "Current NCI Preclinical Antitumor Screening in Vivo: Results of Tumor Panel Screening, 1976-1982, and Future Directions", Advances in Pharmacology and Chemotherapy, 20, 1-20, (1984).
Venditti, J.M., "The National Cancer Institute Antitumor Drug Discovery Program, Current and Future Perspectives: A Commentary", Cancer Treatment Reports, 67, 767-772, (Sep., 1983).
Walser, J., et al., "Mode of Action of Illudin S", Antimicrob. Ag. Chemother., 3(3), 357-362, (1973).
Weinreb, S.M., "Fulvenes Derived from Illudin S", Tetrahedron Ltrs., 38, 3489-3491, (1971).
Curtis et al, Tetrahedron Letters, 36(12), pp. 1989-1992, 1995.

Affiliated with

Also associated with

Rating

Total synthesis of antitumor acylfulvenes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Total synthesis of antitumor acylfulvenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Total synthesis of antitumor acylfulvenes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-864385